Ogilvy-Stuart A L, Clayton P E, Shalet S M
Department of Endocrinology, Christie Hospital, Manchester, United Kingdom.
J Clin Endocrinol Metab. 1994 Jun;78(6):1282-6. doi: 10.1210/jcem.78.6.8200926.
Low doses of cranial irradiation (18-24 gray) employed in the management of acute lymphoblastic leukemia may cause early or precocious puberty, predominantly in girls. To determine whether this sexual dichotomy exists at higher irradiation doses (25-47 gray), the onset of puberty was identified in 46 GH-deficient children (30 males) previously irradiated for a brain tumor not involving the hypothalamic-pituitary axis and compared with the normal pubertal standards of Marshall and Tanner. Age at irradiation was at least 2 SD below the mean age of pubertal onset in normal children. There was a significant linear association between age at irradiation and age at onset of puberty. The onset of puberty occurred at an early age in both sexes (mean, 8.51 yr in girls and 9.21 yr in boys plus 0.29 yr for every year of age at irradiation). For example, the estimated age at onset of puberty in a boy irradiated at 2 yr of age would be 9.79 yr, and that for a boy irradiated at 9 yr of age would be 11.82 yr. In the context of GH deficiency, which is usually associated with a delay in the onset of puberty, this is abnormal. At each age of irradiation, the estimated age at the onset of puberty was approximately 0.7 yr earlier in girls than boys. A similar trend was seen for bone age, which was abnormally early at the time of pubertal onset (mean, 7.39 yr in girls and 8.66 yr in boys plus 0.25 yr for every year of age at the time of irradiation). At the doses of irradiation employed in the treatment of brain tumors, radiation-induced early puberty is not restricted to girls. The clinical consequence of early puberty in the management of poor growth associated with radiation-induced GH deficiency is to foreshorten the time available for treatment with GH.
用于急性淋巴细胞白血病治疗的低剂量颅脑照射(18 - 24 格雷)可能会导致青春期提前出现,主要发生在女孩中。为了确定在更高照射剂量(25 - 47 格雷)下是否存在这种性别差异,对 46 名生长激素缺乏儿童(30 名男性)进行了研究,这些儿童之前因脑部肿瘤接受过照射,肿瘤未累及下丘脑 - 垂体轴,并将其青春期开始时间与马歇尔和坦纳的正常青春期标准进行比较。照射时的年龄至少比正常儿童青春期开始的平均年龄低 2 个标准差。照射时的年龄与青春期开始的年龄之间存在显著的线性关联。青春期在两性中均提前出现(女孩平均为 8.51 岁,男孩为 9.21 岁,每照射一年增加 0.29 岁)。例如,2 岁时接受照射的男孩青春期开始的估计年龄为 9.79 岁,9 岁时接受照射的男孩则为 11.82 岁。在通常与青春期延迟相关的生长激素缺乏的情况下,这是异常的。在每个照射年龄,女孩青春期开始的估计年龄比男孩早约 0.7 岁。骨龄也有类似趋势,在青春期开始时骨龄异常提前(女孩平均为 7.39 岁,男孩为 8.66 岁,每照射一年增加 0.25 岁)。在用于治疗脑部肿瘤的照射剂量下,辐射诱导的青春期提前并不局限于女孩。在与辐射诱导的生长激素缺乏相关的生长发育不良管理中,青春期提前的临床后果是缩短了使用生长激素治疗的可用时间。